Munzur, A. D., Herberts, C., Kwan, E. M., Emmett, L., Sandhu, S., Buteau, J. P., Iravani, A., Joshua, A. M., Francis, R. J., Lee, S. T., Scott, A. M., Martin, A. J., Stockler, M. R., Zhang, A. Y., Williams, S. G., Bacon, J. V., Azad, A., Davis, I. D., Hofman, M. S., Wyatt, A. W. (2025). Clonal hematopoiesis (CH) in participants with metastatic castration-resistant prostate cancer (mCRPC) receiving 177 Lu-PSMA-617 or cabazitaxel: An exploratory post-hoc analysis of a randomized phase II trial (TheraP; ANZUP 1603).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5020